IKNA
Price
$1.34
Change
-$0.03 (-2.19%)
Updated
Jun 25 closing price
Capitalization
64.67M
42 days until earnings call
VNDA
Price
$4.61
Change
+$0.11 (+2.44%)
Updated
Jun 25 closing price
Capitalization
271.69M
28 days until earnings call
Interact to see
Advertisement

IKNA vs VNDA

Header iconIKNA vs VNDA Comparison
Open Charts IKNA vs VNDABanner chart's image
Ikena Oncology
Price$1.34
Change-$0.03 (-2.19%)
Volume$88.19K
Capitalization64.67M
Vanda Pharmaceuticals
Price$4.61
Change+$0.11 (+2.44%)
Volume$469.36K
Capitalization271.69M
IKNA vs VNDA Comparison Chart in %
Loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKNA vs. VNDA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a Buy and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (IKNA: $1.34 vs. VNDA: $4.61)
Brand notoriety: IKNA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 91% vs. VNDA: 103%
Market capitalization -- IKNA: $64.67M vs. VNDA: $271.69M
IKNA [@Biotechnology] is valued at $64.67M. VNDA’s [@Biotechnology] market capitalization is $271.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • IKNA’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, IKNA is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • IKNA’s TA Score: 5 bullish, 5 bearish.
  • VNDA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than IKNA.

Price Growth

IKNA (@Biotechnology) experienced а -2.19% price change this week, while VNDA (@Biotechnology) price change was +1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

IKNA is expected to report earnings on Aug 07, 2025.

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($272M) has a higher market cap than IKNA($64.7M). VNDA YTD gains are higher at: -3.758 vs. IKNA (-18.293). IKNA has higher annual earnings (EBITDA): -47.91M vs. VNDA (-64.56M). VNDA has more cash in the bank: 341M vs. IKNA (114M). IKNA has less debt than VNDA: IKNA (6.61M) vs VNDA (11.7M). VNDA has higher revenues than IKNA: VNDA (201M) vs IKNA (0).
IKNAVNDAIKNA / VNDA
Capitalization64.7M272M24%
EBITDA-47.91M-64.56M74%
Gain YTD-18.293-3.758487%
P/E RatioN/A126.00-
Revenue0201M-
Total Cash114M341M33%
Total Debt6.61M11.7M56%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNAVNDA
RSI
ODDS (%)
Bearish Trend 1 day ago
62%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
Bullish Trend 1 day ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GROV1.150.06
+5.50%
Grove Collaborative Holdings
NWPX40.08-0.03
-0.06%
Northwest Pipe Company
USPH78.43-0.61
-0.77%
US Physical Therapy
SAIA270.09-5.09
-1.85%
Saia
NVO67.35-3.38
-4.78%
Novo-Nordisk A/S

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ABCZF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
-2.19%
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
-0.50%
VNDA - IKNA
37%
Loosely correlated
+2.44%
SYRE - IKNA
36%
Loosely correlated
+2.01%
VTYX - IKNA
36%
Loosely correlated
-0.41%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AVIR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AVIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+2.44%
AVIR - VNDA
43%
Loosely correlated
+2.66%
EYPT - VNDA
42%
Loosely correlated
+14.81%
IVF - VNDA
40%
Loosely correlated
+2.00%
PGEN - VNDA
40%
Loosely correlated
-5.33%
RYTM - VNDA
39%
Loosely correlated
-2.15%
More